{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:15:09Z","timestamp":1791112509702,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099341","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T20:22:52Z","timestamp":1402690972000},"page":"e99341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Allele-Specific Silencing of Mutant Huntingtin in Rodent Brain and Human Stem Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Val\u00e9rie","family":"Drouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Zala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Feyeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenna\u00eblle","family":"Auregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Cambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Troquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Merienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fany","family":"Bourgois-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymonde","family":"Hassig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Saudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselme L.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hantraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"JP Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/gt.2011.170","article-title":"Using non-coding small RNAs to develop therapies for Huntington's disease","volume":"18","author":"Y Zhang","year":"2011","journal-title":"Gene Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"V Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"RL Boudreau","year":"2009","journal-title":"Mol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"J Hu","year":"2010","journal-title":"Chem Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","author":"A Fiszer","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression","volume":"150","author":"D Yu","year":"2012","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"VM Miller","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"S Alves","year":"2008","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS","volume":"41","author":"ME Ostergaard","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"EL Pfister","year":"2009","journal-title":"Curr Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"MS Lombardi","year":"2009","journal-title":"Exp Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"JB Carroll","year":"2011","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","article-title":"CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup","volume":"84","author":"SC Warby","year":"2009","journal-title":"Am J Hum Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ejhg.2010.229","article-title":"HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia","volume":"19","author":"SC Warby","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","article-title":"Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region","volume":"90","author":"JM Lee","year":"2012","journal-title":"Am J Hum Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"LB Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","article-title":"Gene expression and behaviour in mouse models of HD","volume":"88","author":"KR Bowles","year":"2012","journal-title":"Brain Res Bull"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/156652308786847996","article-title":"Applications of lentiviral vectors for biology and gene therapy of neurological disorders","volume":"8","author":"C Lundberg","year":"2008","journal-title":"Curr Gene Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"EJ Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"M Gray","year":"2008","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"AL Southwell","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1523\/JNEUROSCI.20-15-05587.2000","article-title":"Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus","volume":"20","author":"AF Hottinger","year":"2000","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","article-title":"Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells","volume":"21","author":"M Feyeux","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/humrep\/dei345","article-title":"Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders","volume":"21","author":"I Mateizel","year":"2006","journal-title":"Hum Reprod"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/scd.2010.0120","article-title":"Derivation of Huntington's disease-affected human embryonic stem cell lines","volume":"20","author":"CK Bradley","year":"2011","journal-title":"Stem Cells Dev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11626-010-9300-8","article-title":"High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis","volume":"46","author":"P Tropel","year":"2010","journal-title":"In vitro cellular & developmental biology Animal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"LR Gauthier","year":"2004","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"SM Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"HB Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"PH van Bilsen","year":"2008","journal-title":"Hum Gene Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"LP de Almeida","year":"2002","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"L Naldini","year":"1996","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/10430340050016256","article-title":"Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease","volume":"11","author":"N Deglon","year":"2000","journal-title":"Hum Gene Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"MA Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","article-title":"Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons","volume":"17","author":"D Zala","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"AL Jackson","year":"2003","journal-title":"Nat Biotechnol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e49309","DOI":"10.1371\/journal.pone.0049309","article-title":"siRNA has greatly elevated mismatch tolerance at 3'-UTR sites","volume":"7","author":"N Wei","year":"2012","journal-title":"PLoS ONE"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cub.2008.07.072","article-title":"Importance of translation and nonnucleolytic ago proteins for on-target RNA interference","volume":"18","author":"L Wu","year":"2008","journal-title":"Current biology: CB"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"BL Davidson","year":"2011","journal-title":"Nat Rev Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2012.08.008","article-title":"Singles engage the RNA interference pathway","volume":"150","author":"BL Davidson","year":"2012","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1093\/hmg\/ddr110","article-title":"Genetic therapy for the nervous system","volume":"20","author":"WJ Bowers","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"JM Taymans","year":"2007","journal-title":"Hum Gene Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ymthe.2005.11.009","article-title":"Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders","volume":"13","author":"RJ Mandel","year":"2006","journal-title":"Mol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"F Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"N Cartier","year":"2009","journal-title":"Science"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","article-title":"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1\/2 trial","volume":"383","author":"S Palfi","year":"2014","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T14:37:38Z","timestamp":1565534258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099341"}},"subtitle":[],"editor":[{"given":"David","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099341","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]}}}